These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 6975141

  • 21. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE.
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [Abstract] [Full Text] [Related]

  • 22. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR.
    J Immunol; 1998 Feb 15; 160(4):1659-65. PubMed ID: 9469422
    [Abstract] [Full Text] [Related]

  • 23. Relation between Friend leukemia virus-induced leukemia and genetic control of the host.
    Kitagawa M, Matsubara O, Kasuga T.
    Bull Tokyo Med Dent Univ; 1983 Sep 15; 30(3):95-107. PubMed ID: 6589086
    [Abstract] [Full Text] [Related]

  • 24. Lymphoid cell surface receptor for Moloney leukemia virus envelope glycoprotein gp71. I. Binding characteristics.
    Choppin J, Schaffar-Deshayes L, Debré P, Lévy JP.
    J Immunol; 1981 Jun 15; 126(6):2347-51. PubMed ID: 7229379
    [Abstract] [Full Text] [Related]

  • 25. Properties of murine leukemia-associated suppressor cells. I. Preferential suppression of thymus-dependent antibody responses and the requirement for syngeneity in the K region of the H-2 complex.
    Grinwich KD, Alexander TS, Cerny J.
    J Immunol; 1979 Mar 15; 122(3):1108-15. PubMed ID: 376703
    [No Abstract] [Full Text] [Related]

  • 26. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK, Okimoto M, Kulkarni V, Lander JK, Fan H.
    Virology; 1998 Mar 01; 242(1):60-7. PubMed ID: 9501051
    [Abstract] [Full Text] [Related]

  • 27. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
    Thomas CY, Nuckols JD, Murphy C, Innes D.
    Virology; 1993 Apr 01; 193(2):1013-7. PubMed ID: 8384741
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. T cell recognition of Moloney sarcoma virus proteins. II. Phenotypes of the different lymphocyte subpopulations producing and responding to blastogenic factors and their relative frequencies during tumor regression.
    Lee JC, Enjuanes L, Cicurel L, Ihle JN.
    J Immunol; 1981 Jul 01; 127(1):78-83. PubMed ID: 6972414
    [Abstract] [Full Text] [Related]

  • 30. The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen.
    Iwakura Y, Itagaki K, Ishitsuka C, Yamasaki Y, Matsuzawa A, Yonehara S, Karasawa S, Ueda S, Saijo S.
    J Immunol; 1998 Dec 15; 161(12):6592-8. PubMed ID: 9862686
    [Abstract] [Full Text] [Related]

  • 31. Spontaneous recovery from Friend retrovirus-induced leukemia. Mapping of the Rfv-2 gene in the Q/TL region of mouse MHC.
    Miyazawa M, Nishio J, Wehrly K, David CS, Chesebro B.
    J Immunol; 1992 Mar 15; 148(6):1964-7. PubMed ID: 1541833
    [Abstract] [Full Text] [Related]

  • 32. Genetic control of antinuclear antibodies in mice infected with Rauscher leukemia virus.
    Varet B, Cannat A, Gisselbrecht S.
    Cancer Res; 1977 Apr 15; 37(4):1115-8. PubMed ID: 300277
    [Abstract] [Full Text] [Related]

  • 33. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
    Atencio IA, Belli B, Hobbs M, Cheng SF, Villarreal LP, Fan H.
    Virology; 1995 Oct 01; 212(2):356-66. PubMed ID: 7571405
    [Abstract] [Full Text] [Related]

  • 34. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
    Pepersack L, Lee JC, McEwan R, Ihle JN.
    J Immunol; 1980 Jan 01; 124(1):279-85. PubMed ID: 6965293
    [No Abstract] [Full Text] [Related]

  • 35. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb 01; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 36. Immune selection in murine tumors. Ph.d thesis.
    Svane IM, Engel AM.
    APMIS Suppl; 2003 Feb 01; (106):1-46. PubMed ID: 12739251
    [Abstract] [Full Text] [Related]

  • 37. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M, Tsuji-Kawahara S, Kanari Y.
    Vaccine; 2008 Jun 06; 26(24):2981-96. PubMed ID: 18255203
    [Abstract] [Full Text] [Related]

  • 38. Genetic control of antinuclear antibodies in mice inoculated with the moloney leukaemia virus.
    Piatier D, Debre P, Mach PS, Gisselbrecht S.
    J Immunogenet; 1981 Jun 06; 8(3):177-84. PubMed ID: 6973595
    [Abstract] [Full Text] [Related]

  • 39. Recent studies on the role of the immune response in resistance to virus-induced leukemias and lymphomas.
    Meruelo D, McDevitt HO.
    Semin Hematol; 1978 Oct 06; 15(4):399-419. PubMed ID: 216115
    [No Abstract] [Full Text] [Related]

  • 40. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G, Collavo D, Chieco-Bianchi L.
    J Immunol; 1983 Jul 06; 131(1):16-8. PubMed ID: 6223070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.